Literature DB >> 12176013

NIRF, a novel RING finger protein, is involved in cell-cycle regulation.

Tsutomu Mori1, Yuanyuan Li, Hiroaki Hata, Kazuo Ono, Hideo Kochi.   

Abstract

Through database mining, we found a novel PEST-containing nuclear protein (PCNP). To characterize PCNP, we carried out yeast two-hybrid screening for PCNP-interacting factors. A novel Np95/ICBP90-like RING finger protein (NIRF), which possessed a ubiquitin-like domain, a PHD finger, a YDG/SRA domain and a RING finger, was identified. Interaction between PCNP and NIRF was clarified by mammalian two-hybrid system, GST pull-down assay, and nuclear co-localization. RT-PCR showed that NIRF expression is high in proliferating phase but significantly low in G0/G1 phase in normal TIG-7 and WI-38 cells, while consistently high in tumoral HT-1080 and HepG2 cells, suggesting that NIRF is involved in cell-cycle regulation. The NIRF gene resides in 9p23-24.1 that is altered in numerous types of tumors at the top of frequency. Furthermore, the NIRF gene is just within small amplicons in some tumors, suggesting that PCNP and NIRF might be involved in some aspects of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176013     DOI: 10.1016/s0006-291x(02)00890-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Authors:  Tsutomu Mori; Daisuke D Ikeda; Toshihiko Fukushima; Seiichi Takenoshita; Hideo Kochi
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.

Authors:  Jiqin Zhang; Qinqin Gao; Pishun Li; Xiaoli Liu; Yuanhui Jia; Weicheng Wu; Jiwen Li; Shuo Dong; Haruhiko Koseki; Jiemin Wong
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

3.  HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.

Authors:  Fengjuan Cheng; Guanhua Qian; Xianyun Fang; Jingjie Sun; Siyuan Chen; Rongjuan Chen; Shangjing Liu; Zhaodi Li; Kejia Wu; Shiming Jiang; Yong Chen; Ni Tang; Juan Chen; Changzhu Duan
Journal:  Hepatol Int       Date:  2021-04-19       Impact factor: 6.047

4.  The Roles of the Methyl-CpG Binding Proteins in Cancer.

Authors:  Lee Parry; Alan R Clarke
Journal:  Genes Cancer       Date:  2011-06

Review 5.  Epigenetic mechanisms of depression and antidepressant action.

Authors:  Vincent Vialou; Jian Feng; Alfred J Robison; Eric J Nestler
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

6.  VIM1, a methylcytosine-binding protein required for centromeric heterochromatinization.

Authors:  Hye Ryun Woo; Olga Pontes; Craig S Pikaard; Eric J Richards
Journal:  Genes Dev       Date:  2007-01-22       Impact factor: 11.361

7.  Identification and functional analysis of 9p24 amplified genes in human breast cancer.

Authors:  J Wu; S Liu; G Liu; A Dombkowski; J Abrams; R Martin-Trevino; M S Wicha; S P Ethier; Z-Q Yang
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

8.  The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis.

Authors:  Huarui Lu; Timothy C Hallstrom
Journal:  J Biol Chem       Date:  2013-07-05       Impact factor: 5.157

9.  Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth.

Authors:  Yonchu Jenkins; Vadim Markovtsov; Wayne Lang; Poonam Sharma; Denise Pearsall; Justin Warner; Christian Franci; Betty Huang; Jianing Huang; George C Yam; Joseph P Vistan; Erlina Pali; Jorge Vialard; Michel Janicot; James B Lorens; Donald G Payan; Yasumichi Hitoshi
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

10.  UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.

Authors:  Yohan Oh; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.